In a randomized trial in Burkina Faso, the antimalarial
effects of ivermectin has shown that it has the potential to reduce malaria
episodes. Burkina Faso is a country in western Africa.
Ivermectin reduces new cases of malaria by
making a person’s blood lethal to the mosquitoes who bite them, killing
mosquitoes. It therefore reduces the likelihood of infection of others.
Ivermectin is a drug used to treat parasitic
infections such as head lice, river blindness and scabies. Mosquito-killing
capabilities of the drug has been known, however, it had not previously been
tested for its effects on malaria incidence.
Malaria is disease caused by Plasmodium parasites
that are transmitted to people through the bites of infected female Anopheles
mosquitoes. According to the World Malaria Report 2018, more than 200 million
people were affected by malaria in 2017. Africa has the highest malaria burden.